from the consolidated statement and displayed as cumulative quarterly statement by fiscal year (Company statement will be presented and calculated incase consolidated statement is not available.) - The
in the notification as follows : the first half of the fiscal year 2022 together with an interim management discussion and analysis This case is in the process of inquiry by the inquiry official
the first half of the fiscal year 2022 together with an interim management discussion and analysis This case is in the process of inquiry by the inquiry official. SEC Act S.300 in conjunction with 56
The Securities and Exchange Commission (SEC), in collaboration with the Fiscal Policy Office (FPO), the Deposit Protection Agency (DPA), and the Bank of Thailand (BOT), organized activities to
company and its subsidiaries financial statement for the fiscal year 2015, ended as of December 31, 2015 which details are as following; Results 2015 (Revised Version) 2014 (Revised Version) Increase
than last year. Personal loan Receivables was 338,117 million baht, with the growth of 4% from the same period last year. In the fiscal year 2016, the Company’s total cards reached 7.81 million cards
MDA_E_FY17 Management’s Discussion and Analysis Fiscal year ended February 28, 2018 AEON Thana Sinsap (Thailand) Public Company Limited (“the Company”) already submitted the audited financial
IP_AC/001/2563 February 24, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited
, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like